Drug Approval | October 09, 2021
Gland Pharma receives tentative nod for Sugammadex injection
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
CuraTeQ Biologics is on track for filing a second oncology biosimilar
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses
Subscribe To Our Newsletter & Stay Updated
